The combination of etoposide and platinum for the treatment of thymic neuroendocrine neoplasms: A retrospective analysis
Abstract Background To provide real‐world outcomes for the combination of etoposide and platinum as a first‐line treatment for advanced thymic neuroendocrine neoplasms (TNENs). Methods Retrospective analysis was performed on patients with advanced TNENs confirmed by pathology who received etoposide...
Main Authors: | Yelan Guan, Qifeng Yao, Yue Hao, Xiaohong Zeng, Wenxian Wang, Xiadong Gu, Jing Xiang, Yan Sun, Zhengbo Song |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2023-08-01
|
Series: | Cancer Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/cam4.6245 |
Similar Items
-
Therapeutic efficacy of platinum/etoposide regimens in the treatment of advanced poorly differentiated neuroendocrine carcinomas of the lung: A retrospective analysis
by: Ivana Puliafito, et al.
Published: (2023-01-01) -
Biomarkers of Response to Etoposide-Platinum Chemotherapy in Patients with Grade 3 Neuroendocrine Neoplasms
by: Caroline Lacombe, et al.
Published: (2021-02-01) -
A Single Center Analysis of Thymic Neuroendocrine Tumors
by: Yirui Zhai, et al.
Published: (2022-10-01) -
Comparison of Efficacy and Safety of Platinum-Based Chemotherapy as First-Line Therapy between B3 Thymoma and Thymic Carcinoma
by: Yue Hao, et al.
Published: (2022-12-01) -
Carboplatin and Etoposide for the Treatment of Metastatic Prostate Cancer with or without Neuroendocrine Features: A French Single-Center Experience
by: Jérémy Baude, et al.
Published: (2024-01-01)